title: Response to cyclosporin A and recombinant human erythropoietin in a case of B cell chronic lymphocytic leukemia and pure red cell aplasia.
authors.forename: C
authors.initials: C
authors.lastname: Cesana
authors.forename: C
authors.initials: C
authors.lastname: Carlo-Stella
authors.forename: L
authors.initials: L
authors.lastname: Mangoni
authors.forename: C
authors.initials: C
authors.lastname: Almici
authors.forename: R
authors.initials: R
authors.lastname: Giachetti
authors.forename: M
authors.initials: M
authors.lastname: Zappa
authors.forename: V
authors.initials: V
authors.lastname: Rizzoli
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001803:Blood Transfusion; D002699:Chlorambucil / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D004921:Erythropoietin / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000150:complications / Q000628:therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011990:Receptors, Transferrin / Q000032:analysis; D011994:Recombinant Proteins / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000150:complications / Q000628:therapy*; D017701:Reticulocyte Count
chemical_list: D006454:Hemoglobins; D011990:Receptors, Transferrin; D011994:Recombinant Proteins; D004921:Erythropoietin; D002699:Chlorambucil; D016572:Cyclosporine; D011241:Prednisone